Otsuka Co. (OTCMKTS:OSUKF – Get Free Report) saw a large decline in short interest during the month of April. As of April 30th, there was short interest totaling 420,688 shares, a decline of 49.1% from the April 15th total of 826,439 shares. Based on an average daily volume of 2 shares, the short-interest ratio is presently 210,344.0 days.
Otsuka Price Performance
OSUKF stock opened at $20.77 on Monday. Otsuka has a one year low of $19.00 and a one year high of $21.57. The firm has a 50-day moving average of $20.76 and a two-hundred day moving average of $20.70.
About Otsuka
Otsuka Holdings Co, Ltd., traded as OSUKF on the OTC Market, is a global healthcare group headquartered in Tokyo, Japan. The company operates through its principal subsidiary, Otsuka Pharmaceutical Co, Ltd., and is primarily engaged in the research, development and commercialization of pharmaceutical products and nutraceuticals. Its product portfolio spans central nervous system therapies, cardiovascular and metabolic treatments, nephrology, and oncology, alongside a range of consumer wellness goods such as nutritional beverages and dietary supplements.
The origins of the Otsuka group date back to 1921 with the founding of its predecessor firm, and in 2008 the current holding company structure was established to streamline governance and strategic direction.
Featured Stories
- Five stocks we like better than Otsuka
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
